मैगज़्टर गोल्ड के साथ असीमित हो जाओ

मैगज़्टर गोल्ड के साथ असीमित हो जाओ

10,000 से अधिक पत्रिकाओं, समाचार पत्रों और प्रीमियम कहानियों तक असीमित पहुंच प्राप्त करें सिर्फ

$149.99
 
$74.99/वर्ष

कोशिश गोल्ड - मुक्त

A vigilant consumer is half the battle won

Express Pharma

|

September 2025

Manoj Kochar, President, Authentication Solution Providers' Association (ASPA), in a frank conversation with Viveka Roychowdhury, urges pharma companies to publicly acknowledge the problem of counterfeit medicine, and invest in multi-layered authentication solutions - overt and covert, physical and digital - to deter counterfeiters.

- Viveka Roychowdhury

A vigilant consumer is half the battle won

Agreeing that QR codes, while useful for tracking, are not foolproof authentication tools and are easily cloned, he firmly believes that a vigilant consumer is half the battle won, and hopes that pharma companies can spur consumers to scan QR codes, search for anti-counterfeiting features like holograms etc. He hopes the Ministry of Consumer Affairs takes up ASPA's recommendation to have a medicine-focused Jago Grahak Jago campaign

What are the major findings of ASPA - CRISIL State of Counterfeiting in India Report 2022 on the state of counterfeiting in India with respect to the high-risk pharma sector?

The second edition of the new report on counterfeiting is still a work in progress. It is expected to be launched around September 11, 2025. There were a lot of pretty startling findings in the first edition. Firstly, if you look at the problem of counterfeiting in an overall situation, the Indian pharma industry as per the fiscal 2023 estimates, was about Rs 3 trillion which is clearly one of the largest in the world. Most of it is meant for domestic consumption.

Coming specifically to the counterfeits, which includes spurious and substandard drugs, CDSCO did a survey in 2009 and they estimated that at that point in time, counterfeits or spurious and substandard drugs are about one per cent.

As per WHO, it was around 10 per cent. When we did the State of Counterfeiting in India 2022 report, 20 per cent of the consumers felt that there is counterfeit medicine in the market. The same study also discovered that 25 per cent of the people willingly purchase counterfeit medicines due to nonavailability of the original product and obviously lower cost. OECD did a report in 2020 where they said that India was the origin of 47 per cent in value terms of the total counterfeit value of the goods that was seized by EU custom authorities. This obviously suggests that India is a major hub.

Express Pharma से और कहानियाँ

Express Pharma

Express Pharma

NEEDLES, PENS AND PRESSURE THE GLP-1 CHALLENGE

As GLP-1 therapies transform diabetes and obesity care, demand for prefilled pens and injectors is soaring. Pharma-device collaborations, analytical innovation, and sustainable design will be key to tackle the growing device bottleneck

time to read

7 mins

November 2025

Express Pharma

Express Pharma

Unified standards and smarter design are key to unlocking next-generation HVAC performance

Current HVAC design relies on a diverse, and sometimes confusing, array of guidelines issued by regulatory bodies such as WHO, EU GMP, ISO 14644, ISPE Baseline, and ASHRAE/ISHRAE.

time to read

2 mins

November 2025

Express Pharma

Express Pharma

Kyasanur Forest Disease - How far is a regulatory approved vaccine?

Dr Priyabrata Pattnaik, Former Deputy MD, Indian Immunologicals, informs about the Kyasanur Forest Disease (KFD), a zoonotic viral hemorrhagic fever endemic to parts of India, particularly along the Western Ghats and discusses the current status of developing a regulatory-approved KFD vaccine in India

time to read

3 mins

November 2025

Express Pharma

Express Pharma

India's biopharma industry charts the road from biosimilars to innovation

Express Pharma hosted the maiden Biopharma Leadership Conclave 2025 and brought together industry leaders to discuss how India can move from being the world's leading producer of generics and biosimilars to becoming a hub for innovative, affordable, and high-quality biologics and advanced therapies

time to read

4 mins

November 2025

Express Pharma

Express Pharma

Digital technologies are quietly transforming HVAC into an intelligent compliance partner

Over the last decade, HVAC standards in pharmaceutical manufacturing have undergone a quiet revolution.

time to read

2 mins

November 2025

Express Pharma

Express Pharma

Direct-to-Retail will increasingly complement traditional pharma distribution

Aqualab has crossed Rs 100 crore in just three years, what have been the key drivers behind this growth, and how does the brand plan to achieve the Rs 250 crore target by FY25-26?Aqualab's journey to Rs 100 crore within three years reflects the strength of a simple yet powerful principle, accessibility through proximity. Our growth has been anchored in three areas: a high-velocity retail network that prioritises last-mile availability, a well-diversified therapeutic portfolio spanning acute and chronic segments, and a strong focus on brand trust built through consistent product quality.

time to read

3 mins

November 2025

Express Pharma

Express Pharma

Guaranteeing continuity of medicine supply through AI innovation

Hari Kiran Chereddi highlights how AI is transforming pharma supply chains to ensure uninterrupted medicine availability

time to read

2 mins

November 2025

Express Pharma

PROSOLV® 730: Directly compressible carrier for lipophilic ingredients

Nearly 90 % of molecules in the discovery pipeline and 40 % of drugs with market approval are poorly water soluble. Poor aqueous solubility can lead to low bioavailability resulting in insufficient plasma levels. Oil-based preparations of these APIs, as well as oily APIs in general, present challenges in terms of solid dosage form manufacturing. PROSOLV® 730 was designed to provide a solution to the formulation of BCS class II and IV APIs. It enables the formulation of lipidic APIs or API-loaded lipid systems by facilitating the adsorption of oil, creating a free-flowing, compactible system that can be further formulated. PROSOLV® 730 is a co-processed, high-functionality excipient comprising MCC SILICA COPOVIDONE

time to read

2 mins

November 2025

Express Pharma

Express Pharma

Ensuring Clean Room Integrity with Prime Clean Reset High-Speed Doors: Minimizing Air Permeability and Leakages

High-speed doors for clean rooms are specialized industrial doors essential for maintaining controlled environments. These doors are engineered to be airtight, creating a reliable barrier between different areas of a facility. Their design ensures durability and minimal maintenance, reducing the frequency of repairs and replacements.

time to read

2 mins

November 2025

Express Pharma

Express Pharma

Reimagining cold chain: How IoT secures every pharma mile

Swarup Bose, Co-founder and CEO, Celcius Logistics points out that as the demand for temperature-sensitive medicines surges, maintaining an unbroken cold chain has never been more critical. IoT is emerging as the game-changer that ensures every vial and vaccine arrives potent, safe, and on time

time to read

3 mins

November 2025

Listen

Translate

Share

-
+

Change font size